Elite in Nasopharyngeal Carcinoma

Edwin P. Hui

State Key Laboratory Of Translational Oncology, Hong Kong, 
Sar, CN 
Elite in Nasopharyngeal Carcinoma
State Key Laboratory Of Translational Oncology, Hong Kong, 
Sar, CN 
OverviewLocationsClinical Research

Overview

Edwin Hui practices in Sar, China. Mr. Hui is rated as an Elite expert by MediFind in the treatment of Nasopharyngeal Carcinoma. His top areas of expertise are Nasopharyngeal Carcinoma, Mononucleosis, Liver Cancer, and Colorectal Cancer.

His clinical research consists of co-authoring 111 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 71 articles and participated in 1 clinical trial in the study of Nasopharyngeal Carcinoma.

Gender
Male

Locations

State Key Laboratory Of Translational Oncology, Hong Kong, Sar, China
Other Locations
P.R. China, Pokfulam, China
Kowloon, P.R. China, Hom, China
Lo, China
State Key Laboratory In Oncology In South China And Li Ka Shing Institute Of Health Science, Hong Kong, Lika, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

Efficacy of Recombinant Epstein-Barr Virus (EBV) Vaccine in Patients With Nasopharyngeal Cancer Who Had Residual EBV DNA Load After Conventional Therapy
Efficacy of Recombinant Epstein-Barr Virus (EBV) Vaccine in Patients With Nasopharyngeal Cancer Who Had Residual EBV DNA Load After Conventional Therapy
Enrollment Status: Completed
Publish Date: July 28, 2021
Intervention Type: Biological
Study Drug: Recombinant Epstein-Barr Virus Vaccine
Study Phase: Phase 2

111 Total Publications

ISG15 mRNA transcript level in circulating leucocytes prognostic of overall survival in hepatocellular carcinoma patients and correlated with quality of life disturbances involved in anorexia-cachexia.
ISG15 mRNA transcript level in circulating leucocytes prognostic of overall survival in hepatocellular carcinoma patients and correlated with quality of life disturbances involved in anorexia-cachexia.
Journal: Frontiers in oncology
Published: March 06, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Hui's expertise for a condition
ConditionClose
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile